CLINICAL TRIALS PROFILE FOR XENLETA
✉ Email this page to a colleague
All Clinical Trials for XENLETA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT05111002 ↗ | Lefamulin for M. Genitalium Treatment Failures | Not yet recruiting | Nabriva Therapeutics AG | Phase 1/Phase 2 | 2021-11-30 | The purpose of this drug study is to find out whether the antibiotic lefamulin (trade name Xenleta) will cure Mycoplasma genitalium infections that have not been cured by prior antibiotics while finding out whether it is more effective if the antibiotic doxycycline is taken first. |
| NCT05111002 ↗ | Lefamulin for M. Genitalium Treatment Failures | Not yet recruiting | University of Washington | Phase 1/Phase 2 | 2021-11-30 | The purpose of this drug study is to find out whether the antibiotic lefamulin (trade name Xenleta) will cure Mycoplasma genitalium infections that have not been cured by prior antibiotics while finding out whether it is more effective if the antibiotic doxycycline is taken first. |
| NCT05225805 ↗ | Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis | Not yet recruiting | Nabriva Therapeutics AG | Phase 1 | 2022-02-15 | This study is intended to assess the PK and safety of a single dose of IV and oral formulations of lefamulin in adults with CF. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for XENLETA
Condition Name
Clinical Trial Progress for XENLETA
Clinical Trial Phase
Clinical Trial Sponsors for XENLETA
Sponsor Name
